Andrea Kossler, MD

Stanford University
Palo Alto, California, United States

Disclosure information not submitted.

Presentation(s):

• SUN-400 - Euglycemic Diabetic Ketoacidosis After Teprotumumab: A De Novo Presentation of Type 1 Diabetes

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• ORF49-04 - Characterization of Proptosis Response in the THRIVE Phase 3 Trial of Veligrotug for Active Thyroid Eye Disease (TED)

  Monday, June 15, 2026
  2:00 PM - 2:15 PM CT